Transcripts
Biomarin Pharmaceutical (BMRN) earnings call transcripts
Every Biomarin Pharmaceutical Inc. earnings call Gloomberb has transcribed, with a summary, the guidance given, and what analysts pressed on.
- Q2 2026 earnings call
Management framed Amicus as exceeding integration expectations while competitive pressure on Voxzogo remains manageable and pipeline execution accelerates.
Aug 06, 2026Confident0.84